Telomir Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:TELO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Cash from operating activities -3.86 M-5.07 M-3.69 M -4.91 M Cash from investing activities ——— — Cash from financing activities 3.86 M6.34 M9.71 M 9.33 M Free cash flow -3.86 M-5.07 M-3.69 M -4.91 M

News

Telomir Pharmaceuticals Announces ~$5.6M Investment In PIPE Financing Through Common Stock Issuance

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Maxim Group Initiates Coverage On Telomir Pharmaceuticals with Buy Rating, Announces Price Target of $4

Telo Genomics increases convertible debenture offering to $1.6M

Telo Genomics appoints John Price as new CFO

Rodman & Renshaw initiates Telomir Pharma stock with Buy rating

Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It

Telomir Pharmaceuticals sets CEO incentive awards and salary adjustment

Telomir reports PSA reduction in prostate cancer cells with lead drug

Telomir stock surges after leukemia cell-killing data

Telomir Pharmaceuticals director Craig Eagle resigns from board